Summary & Overview
HCPCS G9956: Perioperative Combination Antiemetic Prophylaxis
HCPCS Level II code G9956 denotes administration of combination prophylactic pharmacologic anti-emetic therapy, defined as at least two anti-emetic agents from different drug classes given preoperatively and/or intraoperatively. This code captures clinical efforts to prevent postoperative nausea and vomiting, a common and significant complication that can affect patient comfort, recovery time, and perioperative outcomes. Nationally, standardized reporting of antiemetic prophylaxis supports quality measurement and care coordination across surgical and anesthesia services.
Key payers included in the discussion are Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of the code’s clinical intent and typical use cases, payer coverage considerations, common modifiers associated with billing for perioperative medication services, and practical coding context such as expected site of service. The publication summarizes benchmarks and policy-relevant points for payers and providers and highlights areas where coding clarity can affect claims processing and quality reporting.
The content is intended to provide a concise reference for clinicians, coding professionals, and policy analysts about when G9956 applies, how it relates to perioperative care, and what to expect in payer interactions and documentation needs. Data not available in the input is noted where applicable.
Billing Code Overview
HCPCS Level II code G9956 indicates that a patient received combination therapy consisting of at least two prophylactic pharmacologic anti-emetic agents of different classes preoperatively and/or intraoperatively. This describes administration of multiple preventive antiemetic medications to reduce the risk of postoperative nausea and vomiting around the time of surgery.
Service type: Combination prophylactic pharmacologic anti-emetic therapy administered in the perioperative period.
Typical site of service: Operating room, preoperative or intraoperative clinical setting, or other surgical/procedural areas where anesthesia and perioperative medications are administered.
Clinical & Coding Specifications
Clinical Context
A 45-year-old female scheduled for elective laparoscopic cholecystectomy receives preoperative assessment in the preoperative clinic. She has a history of severe postoperative nausea and vomiting (PONV) after prior surgeries and is undergoing a general anesthetic for a minimally invasive abdominal procedure. Per the anesthesia plan, the anesthesiologist orders combination prophylaxis consisting of at least two anti-emetic agents from different pharmacologic classes — for example, a 5-HT3 receptor antagonist (ondansetron IV) plus a corticosteroid (dexamethasone IV) administered preoperatively, with an additional intraoperative NK1 receptor antagonist or adjunct agent if indicated. The intraoperative nursing and anesthesia teams document administration times, doses, and clinical indication in the anesthesia record and medication administration record.
Typical workflow steps:
-
Preoperative assessment identifies elevated PONV risk and documents rationale for combination prophylaxis.
-
Informed consent for anesthesia includes review of anti-emetic strategy.
-
Medications are ordered, dispensed, and administered preoperatively and/or intraoperatively by anesthesia personnel.
-
Anesthesia record and medication administration record capture drug names, doses, routes, times, and the clinical indication "PONV prophylaxis".
-
Post-anesthesia care unit staff monitor for effectiveness and adverse effects and document outcomes.
Typical site of service: ambulatory surgery center or hospital operating room and post-anesthesia care unit.
Service type: prophylactic pharmacologic anti-emetic combination therapy administered in the perioperative (preoperative and/or intraoperative) period.